| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.4M | +157.0% | -45.7% |
| R&D Expense | $35.9M | +14.5% | +18.6% |
| SG&A Expense | $8.1M | -22.9% | -0.9% |
| Operating Income | -$30.6M | +16.5% | -122.0% |
| Pre-tax Income | -$27.8M | +16.7% | -209.0% |
| Income Tax | $83K | +453.3% | +93.0% |
| Net Income | -$27.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $45.1M | +2.7% | -59.9% |
| Short-term Investments | $163.8M | -4.6% | -29.6% |
| Accounts Receivable | $3.2M | +90.3% | -80.0% |
| Current Assets | $219.6M | -3.6% | -41.2% |
| Total Assets | $288.3M | -10.5% | -32.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$102.2M | — | — |
| Capital Expenditures | $2.0M | — | — |
| Investing Cash Flow | $78.0M | — | — |
| Financing Cash Flow | $680K | — | — |
| Free Cash Flow | -$104.2M | — | — |
| +16.4% |
| -208.4% |
| EPS (Basic) | -$0.47 | +17.5% | -193.7% |
| EPS (Diluted) | -$0.47 | +17.5% | -193.7% |
| $35.5M |
| -15.5% |
| -19.7% |
| Total Liabilities | $68.5M | -12.4% | -28.5% |
| Stockholders' Equity | $219.8M | -9.9% | -33.4% |